nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Diphemanil Methylsulfate—Tamoxifen—pancreatic cancer	0.304	0.329	CrCrCtD
Mepenzolate—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.11	0.119	CrCrCtD
Mepenzolate—Loperamide—Tamoxifen—pancreatic cancer	0.11	0.119	CrCrCtD
Mepenzolate—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.11	0.119	CrCrCtD
Mepenzolate—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0902	0.0977	CrCrCtD
Mepenzolate—Methadone—Tamoxifen—pancreatic cancer	0.0755	0.0817	CrCrCtD
Mepenzolate—Clofedanol—Tamoxifen—pancreatic cancer	0.0652	0.0706	CrCrCtD
Mepenzolate—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0585	0.0633	CrCrCtD
Mepenzolate—Ageusia—Sunitinib—pancreatic cancer	0.000627	0.0441	CcSEcCtD
Mepenzolate—Ageusia—Docetaxel—pancreatic cancer	0.000357	0.0251	CcSEcCtD
Mepenzolate—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.000342	0.0241	CcSEcCtD
Mepenzolate—Abdominal distension—Sunitinib—pancreatic cancer	0.000321	0.0226	CcSEcCtD
Mepenzolate—Abdominal distension—Irinotecan—pancreatic cancer	0.000264	0.0186	CcSEcCtD
Mepenzolate—Ageusia—Epirubicin—pancreatic cancer	0.000241	0.0169	CcSEcCtD
Mepenzolate—Ageusia—Doxorubicin—pancreatic cancer	0.000223	0.0157	CcSEcCtD
Mepenzolate—Dry mouth—Tamoxifen—pancreatic cancer	0.000216	0.0152	CcSEcCtD
Mepenzolate—Insomnia—Tamoxifen—pancreatic cancer	0.000191	0.0135	CcSEcCtD
Mepenzolate—Insomnia—Erlotinib—pancreatic cancer	0.000189	0.0133	CcSEcCtD
Mepenzolate—Dry mouth—Sunitinib—pancreatic cancer	0.000185	0.013	CcSEcCtD
Mepenzolate—Constipation—Tamoxifen—pancreatic cancer	0.000181	0.0127	CcSEcCtD
Mepenzolate—Constipation—Erlotinib—pancreatic cancer	0.000179	0.0126	CcSEcCtD
Mepenzolate—Urticaria—Tamoxifen—pancreatic cancer	0.000168	0.0118	CcSEcCtD
Mepenzolate—Vision blurred—Fluorouracil—pancreatic cancer	0.000165	0.0116	CcSEcCtD
Mepenzolate—Insomnia—Sunitinib—pancreatic cancer	0.000164	0.0115	CcSEcCtD
Mepenzolate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000156	0.011	CcSEcCtD
Mepenzolate—Constipation—Sunitinib—pancreatic cancer	0.000155	0.0109	CcSEcCtD
Mepenzolate—Asthenia—Tamoxifen—pancreatic cancer	0.000152	0.0107	CcSEcCtD
Mepenzolate—Confusional state—Irinotecan—pancreatic cancer	0.00015	0.0106	CcSEcCtD
Mepenzolate—Asthenia—Erlotinib—pancreatic cancer	0.00015	0.0106	CcSEcCtD
Mepenzolate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000149	0.0105	CcSEcCtD
Mepenzolate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000145	0.0102	CcSEcCtD
Mepenzolate—Confusional state—Fluorouracil—pancreatic cancer	0.000144	0.0101	CcSEcCtD
Mepenzolate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000143	0.0101	CcSEcCtD
Mepenzolate—Dizziness—Tamoxifen—pancreatic cancer	0.00014	0.00984	CcSEcCtD
Mepenzolate—Tachycardia—Fluorouracil—pancreatic cancer	0.000139	0.00981	CcSEcCtD
Mepenzolate—Dizziness—Erlotinib—pancreatic cancer	0.000138	0.00973	CcSEcCtD
Mepenzolate—Insomnia—Irinotecan—pancreatic cancer	0.000135	0.00949	CcSEcCtD
Mepenzolate—Vomiting—Tamoxifen—pancreatic cancer	0.000134	0.00946	CcSEcCtD
Mepenzolate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000133	0.00939	CcSEcCtD
Mepenzolate—Vomiting—Erlotinib—pancreatic cancer	0.000133	0.00936	CcSEcCtD
Mepenzolate—Somnolence—Irinotecan—pancreatic cancer	0.000133	0.00933	CcSEcCtD
Mepenzolate—Headache—Tamoxifen—pancreatic cancer	0.000132	0.00932	CcSEcCtD
Mepenzolate—Insomnia—Gemcitabine—pancreatic cancer	0.000131	0.00925	CcSEcCtD
Mepenzolate—Headache—Erlotinib—pancreatic cancer	0.000131	0.00922	CcSEcCtD
Mepenzolate—Asthenia—Sunitinib—pancreatic cancer	0.00013	0.00914	CcSEcCtD
Mepenzolate—Insomnia—Fluorouracil—pancreatic cancer	0.000129	0.00909	CcSEcCtD
Mepenzolate—Somnolence—Gemcitabine—pancreatic cancer	0.000129	0.00909	CcSEcCtD
Mepenzolate—Constipation—Irinotecan—pancreatic cancer	0.000128	0.00897	CcSEcCtD
Mepenzolate—Somnolence—Fluorouracil—pancreatic cancer	0.000127	0.00894	CcSEcCtD
Mepenzolate—Nausea—Tamoxifen—pancreatic cancer	0.000126	0.00884	CcSEcCtD
Mepenzolate—Constipation—Gemcitabine—pancreatic cancer	0.000124	0.00874	CcSEcCtD
Mepenzolate—Nausea—Erlotinib—pancreatic cancer	0.000124	0.00874	CcSEcCtD
Mepenzolate—Abdominal distension—Epirubicin—pancreatic cancer	0.000123	0.00866	CcSEcCtD
Mepenzolate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000123	0.00865	CcSEcCtD
Mepenzolate—Dizziness—Sunitinib—pancreatic cancer	0.00012	0.00842	CcSEcCtD
Mepenzolate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00012	0.00842	CcSEcCtD
Mepenzolate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000118	0.00828	CcSEcCtD
Mepenzolate—Vomiting—Sunitinib—pancreatic cancer	0.000115	0.0081	CcSEcCtD
Mepenzolate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000114	0.00802	CcSEcCtD
Mepenzolate—Urticaria—Fluorouracil—pancreatic cancer	0.000113	0.00798	CcSEcCtD
Mepenzolate—Headache—Sunitinib—pancreatic cancer	0.000113	0.00798	CcSEcCtD
Mepenzolate—Palpitations—Docetaxel—pancreatic cancer	0.000112	0.00786	CcSEcCtD
Mepenzolate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00011	0.00773	CcSEcCtD
Mepenzolate—Drowsiness—Epirubicin—pancreatic cancer	0.000109	0.00767	CcSEcCtD
Mepenzolate—Nausea—Sunitinib—pancreatic cancer	0.000108	0.00757	CcSEcCtD
Mepenzolate—Asthenia—Irinotecan—pancreatic cancer	0.000107	0.00753	CcSEcCtD
Mepenzolate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000105	0.00741	CcSEcCtD
Mepenzolate—Dry mouth—Docetaxel—pancreatic cancer	0.000105	0.0074	CcSEcCtD
Mepenzolate—Asthenia—Gemcitabine—pancreatic cancer	0.000104	0.00733	CcSEcCtD
Mepenzolate—Confusional state—Docetaxel—pancreatic cancer	0.000104	0.00731	CcSEcCtD
Mepenzolate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000103	0.00725	CcSEcCtD
Mepenzolate—Drowsiness—Doxorubicin—pancreatic cancer	0.000101	0.0071	CcSEcCtD
Mepenzolate—Tachycardia—Docetaxel—pancreatic cancer	0.000101	0.00708	CcSEcCtD
Mepenzolate—Dizziness—Irinotecan—pancreatic cancer	9.86e-05	0.00694	CcSEcCtD
Mepenzolate—Vomiting—Irinotecan—pancreatic cancer	9.48e-05	0.00667	CcSEcCtD
Mepenzolate—Dizziness—Fluorouracil—pancreatic cancer	9.45e-05	0.00665	CcSEcCtD
Mepenzolate—Headache—Irinotecan—pancreatic cancer	9.34e-05	0.00657	CcSEcCtD
Mepenzolate—Insomnia—Docetaxel—pancreatic cancer	9.33e-05	0.00656	CcSEcCtD
Mepenzolate—Vomiting—Gemcitabine—pancreatic cancer	9.24e-05	0.0065	CcSEcCtD
Mepenzolate—Somnolence—Docetaxel—pancreatic cancer	9.17e-05	0.00645	CcSEcCtD
Mepenzolate—Headache—Gemcitabine—pancreatic cancer	9.1e-05	0.0064	CcSEcCtD
Mepenzolate—Vomiting—Fluorouracil—pancreatic cancer	9.08e-05	0.00639	CcSEcCtD
Mepenzolate—Headache—Fluorouracil—pancreatic cancer	8.95e-05	0.0063	CcSEcCtD
Mepenzolate—Nausea—Irinotecan—pancreatic cancer	8.86e-05	0.00623	CcSEcCtD
Mepenzolate—Constipation—Docetaxel—pancreatic cancer	8.82e-05	0.0062	CcSEcCtD
Mepenzolate—Nausea—Gemcitabine—pancreatic cancer	8.63e-05	0.00607	CcSEcCtD
Mepenzolate—Feeling abnormal—Docetaxel—pancreatic cancer	8.5e-05	0.00598	CcSEcCtD
Mepenzolate—Nausea—Fluorouracil—pancreatic cancer	8.49e-05	0.00597	CcSEcCtD
Mepenzolate—Tension—Epirubicin—pancreatic cancer	8.36e-05	0.00588	CcSEcCtD
Mepenzolate—Nervousness—Epirubicin—pancreatic cancer	8.28e-05	0.00582	CcSEcCtD
Mepenzolate—Vision blurred—Epirubicin—pancreatic cancer	8.03e-05	0.00565	CcSEcCtD
Mepenzolate—Tension—Doxorubicin—pancreatic cancer	7.74e-05	0.00544	CcSEcCtD
Mepenzolate—Nervousness—Doxorubicin—pancreatic cancer	7.66e-05	0.00539	CcSEcCtD
Mepenzolate—Hypersensitivity—Docetaxel—pancreatic cancer	7.6e-05	0.00534	CcSEcCtD
Mepenzolate—Palpitations—Epirubicin—pancreatic cancer	7.53e-05	0.0053	CcSEcCtD
Mepenzolate—Vision blurred—Doxorubicin—pancreatic cancer	7.43e-05	0.00523	CcSEcCtD
Mepenzolate—Asthenia—Docetaxel—pancreatic cancer	7.4e-05	0.00521	CcSEcCtD
Mepenzolate—Dry mouth—Epirubicin—pancreatic cancer	7.1e-05	0.00499	CcSEcCtD
Mepenzolate—Confusional state—Epirubicin—pancreatic cancer	7.01e-05	0.00493	CcSEcCtD
Mepenzolate—Palpitations—Doxorubicin—pancreatic cancer	6.97e-05	0.0049	CcSEcCtD
Mepenzolate—Anaphylactic shock—Epirubicin—pancreatic cancer	6.95e-05	0.00489	CcSEcCtD
Mepenzolate—Dizziness—Docetaxel—pancreatic cancer	6.82e-05	0.0048	CcSEcCtD
Mepenzolate—Tachycardia—Epirubicin—pancreatic cancer	6.79e-05	0.00478	CcSEcCtD
Mepenzolate—Dry mouth—Doxorubicin—pancreatic cancer	6.57e-05	0.00462	CcSEcCtD
Mepenzolate—Vomiting—Docetaxel—pancreatic cancer	6.56e-05	0.00461	CcSEcCtD
Mepenzolate—Confusional state—Doxorubicin—pancreatic cancer	6.49e-05	0.00457	CcSEcCtD
Mepenzolate—Headache—Docetaxel—pancreatic cancer	6.46e-05	0.00454	CcSEcCtD
Mepenzolate—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.44e-05	0.00453	CcSEcCtD
Mepenzolate—Insomnia—Epirubicin—pancreatic cancer	6.29e-05	0.00443	CcSEcCtD
Mepenzolate—Tachycardia—Doxorubicin—pancreatic cancer	6.28e-05	0.00442	CcSEcCtD
Mepenzolate—Somnolence—Epirubicin—pancreatic cancer	6.18e-05	0.00435	CcSEcCtD
Mepenzolate—Nausea—Docetaxel—pancreatic cancer	6.12e-05	0.00431	CcSEcCtD
Mepenzolate—Constipation—Epirubicin—pancreatic cancer	5.95e-05	0.00418	CcSEcCtD
Mepenzolate—Insomnia—Doxorubicin—pancreatic cancer	5.82e-05	0.0041	CcSEcCtD
Mepenzolate—Feeling abnormal—Epirubicin—pancreatic cancer	5.73e-05	0.00403	CcSEcCtD
Mepenzolate—Somnolence—Doxorubicin—pancreatic cancer	5.72e-05	0.00403	CcSEcCtD
Mepenzolate—Urticaria—Epirubicin—pancreatic cancer	5.53e-05	0.00389	CcSEcCtD
Mepenzolate—Constipation—Doxorubicin—pancreatic cancer	5.5e-05	0.00387	CcSEcCtD
Mepenzolate—Feeling abnormal—Doxorubicin—pancreatic cancer	5.3e-05	0.00373	CcSEcCtD
Mepenzolate—Hypersensitivity—Epirubicin—pancreatic cancer	5.12e-05	0.00361	CcSEcCtD
Mepenzolate—Urticaria—Doxorubicin—pancreatic cancer	5.11e-05	0.0036	CcSEcCtD
Mepenzolate—Asthenia—Epirubicin—pancreatic cancer	4.99e-05	0.00351	CcSEcCtD
Mepenzolate—Hypersensitivity—Doxorubicin—pancreatic cancer	4.74e-05	0.00334	CcSEcCtD
Mepenzolate—Asthenia—Doxorubicin—pancreatic cancer	4.62e-05	0.00325	CcSEcCtD
Mepenzolate—Dizziness—Epirubicin—pancreatic cancer	4.6e-05	0.00324	CcSEcCtD
Mepenzolate—Vomiting—Epirubicin—pancreatic cancer	4.42e-05	0.00311	CcSEcCtD
Mepenzolate—Headache—Epirubicin—pancreatic cancer	4.36e-05	0.00307	CcSEcCtD
Mepenzolate—Dizziness—Doxorubicin—pancreatic cancer	4.26e-05	0.00299	CcSEcCtD
Mepenzolate—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	4.22e-05	0.000679	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.22e-05	0.000678	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.2e-05	0.000676	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	4.19e-05	0.000675	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CNR1—pancreatic cancer	4.19e-05	0.000674	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	4.17e-05	0.000671	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	4.16e-05	0.000669	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NRP1—pancreatic cancer	4.16e-05	0.000669	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	4.15e-05	0.000667	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	4.15e-05	0.000667	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	4.13e-05	0.000665	CbGpPWpGaD
Mepenzolate—Nausea—Epirubicin—pancreatic cancer	4.13e-05	0.00291	CcSEcCtD
Mepenzolate—CHRM3—Metabolism—GLP1R—pancreatic cancer	4.11e-05	0.000661	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	4.11e-05	0.000661	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	4.11e-05	0.000661	CbGpPWpGaD
Mepenzolate—Vomiting—Doxorubicin—pancreatic cancer	4.09e-05	0.00288	CcSEcCtD
Mepenzolate—CHRM1—Signaling by GPCR—GCG—pancreatic cancer	4.04e-05	0.000651	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—DPYD—pancreatic cancer	4.04e-05	0.00065	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	4.03e-05	0.000648	CbGpPWpGaD
Mepenzolate—Headache—Doxorubicin—pancreatic cancer	4.03e-05	0.00284	CcSEcCtD
Mepenzolate—CHRM1—Signaling Pathways—HEY2—pancreatic cancer	4e-05	0.000644	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	3.99e-05	0.000642	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	3.99e-05	0.000642	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—TP53—pancreatic cancer	3.96e-05	0.000636	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	3.95e-05	0.000636	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GAST—pancreatic cancer	3.91e-05	0.000629	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GAST—pancreatic cancer	3.9e-05	0.000627	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	3.88e-05	0.000623	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	3.86e-05	0.000621	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GAST—pancreatic cancer	3.86e-05	0.000621	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGTR1—pancreatic cancer	3.86e-05	0.000621	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	3.85e-05	0.000619	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SLC2A2—pancreatic cancer	3.84e-05	0.000617	CbGpPWpGaD
Mepenzolate—Nausea—Doxorubicin—pancreatic cancer	3.82e-05	0.00269	CcSEcCtD
Mepenzolate—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	3.81e-05	0.000613	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SCT—pancreatic cancer	3.71e-05	0.000596	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HEY1—pancreatic cancer	3.71e-05	0.000596	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SCT—pancreatic cancer	3.7e-05	0.000594	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	3.7e-05	0.000594	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SCT—pancreatic cancer	3.66e-05	0.000589	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	3.66e-05	0.000589	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.59e-05	0.000577	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.57e-05	0.000575	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCK—pancreatic cancer	3.54e-05	0.000569	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCK—pancreatic cancer	3.53e-05	0.000567	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCK—pancreatic cancer	3.49e-05	0.000562	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CNR2—pancreatic cancer	3.45e-05	0.000554	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GLP1R—pancreatic cancer	3.45e-05	0.000554	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CXCL8—pancreatic cancer	3.44e-05	0.000554	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	3.44e-05	0.000553	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	3.44e-05	0.000553	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	3.43e-05	0.000552	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	3.4e-05	0.000547	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	3.4e-05	0.000547	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	3.4e-05	0.000547	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	3.39e-05	0.000545	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	3.38e-05	0.000544	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	3.35e-05	0.000538	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	3.29e-05	0.000529	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	3.28e-05	0.000527	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	3.25e-05	0.000522	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	3.24e-05	0.000521	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	3.23e-05	0.00052	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	3.2e-05	0.000515	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SHH—pancreatic cancer	3.09e-05	0.000497	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SHH—pancreatic cancer	3.08e-05	0.000496	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	3.07e-05	0.000494	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	3.06e-05	0.000493	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	3.05e-05	0.000491	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SHH—pancreatic cancer	3.05e-05	0.000491	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	3.04e-05	0.00049	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	3.03e-05	0.000488	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	3.01e-05	0.000485	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD44—pancreatic cancer	2.97e-05	0.000478	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	2.93e-05	0.000471	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	2.93e-05	0.000471	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	2.92e-05	0.00047	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	2.92e-05	0.00047	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	2.89e-05	0.000465	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	2.89e-05	0.000465	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GCG—pancreatic cancer	2.85e-05	0.000458	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SST—pancreatic cancer	2.68e-05	0.000431	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—STK11—pancreatic cancer	2.68e-05	0.000431	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SST—pancreatic cancer	2.67e-05	0.00043	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SST—pancreatic cancer	2.65e-05	0.000426	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.64e-05	0.000425	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.64e-05	0.000424	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	2.62e-05	0.000422	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	2.61e-05	0.000421	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	2.61e-05	0.00042	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.61e-05	0.00042	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	2.6e-05	0.000419	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	2.59e-05	0.000417	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	2.58e-05	0.000415	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	2.47e-05	0.000398	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	2.47e-05	0.000397	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	2.44e-05	0.000393	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.4e-05	0.000386	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	2.39e-05	0.000385	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GCG—pancreatic cancer	2.39e-05	0.000384	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GCG—pancreatic cancer	2.38e-05	0.000383	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.37e-05	0.000381	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GCG—pancreatic cancer	2.36e-05	0.000379	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.32e-05	0.000374	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.32e-05	0.000373	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TYMS—pancreatic cancer	2.3e-05	0.000371	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.29e-05	0.000369	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.28e-05	0.000367	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	2.27e-05	0.000365	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	2.25e-05	0.000362	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STK11—pancreatic cancer	2.25e-05	0.000361	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STK11—pancreatic cancer	2.24e-05	0.00036	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STK11—pancreatic cancer	2.22e-05	0.000357	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.11e-05	0.000339	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	2.1e-05	0.000338	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.08e-05	0.000335	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.03e-05	0.000326	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.02e-05	0.000325	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2e-05	0.000322	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.97e-05	0.000316	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	1.96e-05	0.000315	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.95e-05	0.000313	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	1.94e-05	0.000312	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	1.94e-05	0.000312	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.92e-05	0.000309	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HES1—pancreatic cancer	1.92e-05	0.000309	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HES1—pancreatic cancer	1.91e-05	0.000308	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HES1—pancreatic cancer	1.9e-05	0.000305	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—pancreatic cancer	1.87e-05	0.000301	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.84e-05	0.000296	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	1.83e-05	0.000295	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.82e-05	0.000292	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	1.77e-05	0.000284	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	1.76e-05	0.000283	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.75e-05	0.000281	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CG—pancreatic cancer	1.69e-05	0.000272	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TERT—pancreatic cancer	1.68e-05	0.000271	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TERT—pancreatic cancer	1.68e-05	0.00027	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.66e-05	0.000267	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARG—pancreatic cancer	1.63e-05	0.000262	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.61e-05	0.000259	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	1.61e-05	0.000258	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	1.6e-05	0.000258	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	1.6e-05	0.000257	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.59e-05	0.000256	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.59e-05	0.000255	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—pancreatic cancer	1.57e-05	0.000253	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—pancreatic cancer	1.57e-05	0.000252	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.55e-05	0.00025	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KDR—pancreatic cancer	1.54e-05	0.000248	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KDR—pancreatic cancer	1.53e-05	0.000247	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.52e-05	0.000244	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CD—pancreatic cancer	1.49e-05	0.000239	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.46e-05	0.000236	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	1.46e-05	0.000235	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.45e-05	0.000233	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	1.45e-05	0.000233	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.45e-05	0.000233	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.43e-05	0.00023	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.42e-05	0.000228	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.42e-05	0.000228	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	1.41e-05	0.000227	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	1.41e-05	0.000227	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EGF—pancreatic cancer	1.4e-05	0.000225	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.4e-05	0.000225	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.4e-05	0.000225	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.4e-05	0.000225	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.38e-05	0.000223	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.000208	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.29e-05	0.000208	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.29e-05	0.000207	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.28e-05	0.000206	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1.28e-05	0.000205	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.25e-05	0.000201	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.24e-05	0.0002	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.23e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.23e-05	0.000198	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	1.23e-05	0.000198	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.22e-05	0.000196	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.22e-05	0.000196	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.22e-05	0.000196	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	1.2e-05	0.000194	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.12e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTEN—pancreatic cancer	1.12e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.12e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.11e-05	0.000178	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.09e-05	0.000175	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	1.08e-05	0.000174	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	1.07e-05	0.000173	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.04e-05	0.000168	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	1.04e-05	0.000167	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.04e-05	0.000167	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	1.03e-05	0.000166	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	1.03e-05	0.000166	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	1.02e-05	0.000165	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.01e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	1.01e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	1e-05	0.000161	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	9.96e-06	0.00016	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	9.96e-06	0.00016	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	9.87e-06	0.000159	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	9.73e-06	0.000156	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	9.7e-06	0.000156	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	9.63e-06	0.000155	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	9.6e-06	0.000154	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	9.6e-06	0.000154	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	9.51e-06	0.000153	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	9.45e-06	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	9.42e-06	0.000151	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	9.39e-06	0.000151	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	9.36e-06	0.000151	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	9.32e-06	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	9.27e-06	0.000149	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	9.16e-06	0.000147	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	9.13e-06	0.000147	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	9.04e-06	0.000145	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SRC—pancreatic cancer	8.71e-06	0.00014	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SRC—pancreatic cancer	8.68e-06	0.00014	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SRC—pancreatic cancer	8.6e-06	0.000138	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	8.48e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	8.45e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	8.4e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	8.38e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	8.37e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	8.37e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	8.35e-06	0.000134	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	8.29e-06	0.000133	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	8.27e-06	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CA—pancreatic cancer	7.9e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MYC—pancreatic cancer	7.8e-06	0.000126	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	7.78e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MYC—pancreatic cancer	7.78e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	7.76e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MYC—pancreatic cancer	7.7e-06	0.000124	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	7.68e-06	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	7.63e-06	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	7.61e-06	0.000122	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	7.53e-06	0.000121	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	7.21e-06	0.000116	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	7.19e-06	0.000116	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	7.12e-06	0.000114	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	6.62e-06	0.000107	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	6.6e-06	0.000106	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	6.54e-06	0.000105	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKT1—pancreatic cancer	6.45e-06	0.000104	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TP53—pancreatic cancer	6.41e-06	0.000103	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TP53—pancreatic cancer	6.39e-06	0.000103	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TP53—pancreatic cancer	6.33e-06	0.000102	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	6.13e-06	9.86e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	6.11e-06	9.83e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	6.05e-06	9.73e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	5.41e-06	8.71e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	5.39e-06	8.68e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	5.34e-06	8.59e-05	CbGpPWpGaD
